AZN (AstraZeneca PLC) Company Cash Volume

Graphic logo of AstraZeneca Plc (AZN)

AstraZeneca PLC (AZN) relies on a powerful network of plants and centers in the US, Sweden, and Britain to produce complex biologics. The company's cash position visualizes current liquidity, where 8.16 shows the current volume of this metric. Growth in the oncology portfolio is scaling profits, although risks remain linked to patent expirations and uncertainty regarding the outcomes of clinical trials for new drugs.

AstraZeneca Plc - AZN Company Total Cash Volume (period 07/04/2022 - 11/21/2026)

AstraZeneca (AZN) - metric breakdowns and financial figures

- stock value and consensus price forecast:
- business market valuation indicators:
Analysis of all company metrics:astrazeneca.com
Signature product of astrazeneca.com

AstraZeneca PLC (AZN) maintains a high dependence on external contract manufacturers and research centers, which necessitates the constant availability of liquid reserves. This metric measures the volume of available cash, forming a defensive buffer against operational risks and crises. By analyzing the cash position chart, an investor determines the burn rate and the efficiency of working capital management. A stable cash balance confirms the business's financial stability and justifies its market valuation.